EPIGENETIC DETERMINANTS CONFERRING GLUCOCORTICOID RESISTANCE IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Yashna Walia, 4160410

DIGITAL DROPLET PCR FOR MINIMAL RESIDUAL DISEASE MONITORING IN PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT FROM THE PROSPECTIVE NORTHERN ITALY LEUKEMIA GROUP (NILG) ALL 10/07 STUDY

EHA Library, Francesco Ballardini, 4160411

DRUG-RESPONSE MODULATING GENES IN ETV6::RUNX1 CHILDHOOD LEUKEMIA

EHA Library, Laura Oksa, 4160415

CAPTURE PROFILING REVEALS AGE-RELATED IG/TR PROFILES, MUTATIONAL PATTERNS AND CLONAL HAEMATOPOIESIS SIGNATURES IN ADULT PATIENTS WITH ALL

EHA Library, Cecilia Bozzetti, 4160416

ANTIBIOTIC-RELATED MICROBIOME DYSBIOSIS DAMPENS HEMATOLOGIC RECOVERY AFTER CD19 CAR-T CELL INFUSION

EHA Library, Jiachen Liu, 4160419

L-ASPARAGINASE ALTERS REDOX HOMEOSTASIS IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Matus Kolarik, 4160423

ROLE OF TP53 MUTATIONS IN REFINING PROGNOSIS OF KTM2A-REARRANGED ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Mariangela Di Trani, 4160425

NOTCH1 TRANSLOCATIONS DEFINE A SPECIFIC SUBTYPE OF HIGH-RISK CORTICAL TYPE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Martina Lucarelli, 4160426

BCR::ABL1 BALANCES CELLULAR DEMAND AND SUPPLY BY JOINTLY ENGAGING STAT5 SIGNALING AND GLYCOLYTIC METABOLISM DOWNSTREAM OF INTERLEUKIN 7 RECEPTOR IN MURINE PREB CELLS

EHA Library, Dennis Das Gupta, 4160429

TARGETING ONCOGENE-INDUCED SENESCENCE IN ETV6::RUNX1 PRE-LEUKEMIC CELLS

EHA Library, Mayla Bertagna, 4160430

INDUCTION OF ONTOGENY-SPECIFIC PRE-LEUKEMIC STEM CELLS IN A KMT2A::AFF1 MURINE MODEL

EHA Library, Ariana Calderón, 4160431

THERAPEUTIC EFFICACY OF BIOMIMETIC NANODRUG CX4945 IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yan Wang, 4160432

THE EXPRESSION AND FUNCTION OF NINJURIN2 IN ACUTE T-LYMPHOID LEUKEMIA

EHA Library, Hongxia Chen, 4160437

IDENTIFYING SYNERGISTIC ACTIVITIES OF COMBINED INHIBITION OF TYROSINE KINASES AND ANTI-APOPTOTIC MOLECULES IN ABL1 FUSION-POSITIVE ALL

EHA Library, Johanna Bender, 4160439

ROLE OF FRUCTOSE TRANSPORTER (GLUT5) EXPRESSION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Serene Xavier, 4160440

REAL-WORLD OUTCOMES OF ADULT B-ALL PATIENTS WHO EXPERIENCE RELAPSED OR REFRACTORY DISEASE FOLLOWING BREXUCABTAGENE AUTOLEUCEL, A STUDY BY THE ROCCA CONSORTIUM

EHA Library, Rawan Faramand, 4160444

LONG-TERM OUTCOMES OF PEBL-ENGINEERED CD7 NANOBODY CAR-T (PA3-17 INJECTION) IN RELAPSED/REFRACTORY T-ALL/LBL: PHASE I TRIAL UPDATE

EHA Library, Meng Lv, 4160445

LEUKEMIC STEM CELL SIGNATURES IMPROVE RISK STRATIFICATION IN T-ALL PATIENTS

EHA Library, YI WEI Lee, 4160446

INOTUZUMAB OZOGAMICIN IN PEDIATRIC CD22-POSITIVE VERY HIGH RISK FIRST RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: PRELIMINARY RESULTS OF THE ITCC-059 STUDY

EHA Library, Erica Brivio, 4160447

COMBINATION OF OLVEREMBATINIB AND VP REGIMEN AS FIRST-LINE THERAPY FOR ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-ARM, MULTICENTRE, PHASE 2 TRIAL

EHA Library, Gaixiang Xu, 4160448

MUTATIONS IN GENES ASSOCIATED WITH CLONAL HEMATOPOIESIS IN PATIENTS WITH ACUTE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Anastasia Vasilieva, 4160449

HIGH IL7R DEFINES FAVORABLE T-ALL PROGNOSIS: CROSS-VALIDATION IN PEDIATRIC COHORTS

EHA Library, Senlin Zhang, 4160450

PEGASPARGASE ADMINISTRATION IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS AGED 55 YEARS OR OLDER TREATED WITH THE PEDIATRIC-INSPIRED PROGRAM LAL1913. A SUBANALYSIS OF THE CAMPUS ALL STUDY

EHA Library, Davide Lazzarotto, 4160452

MULTICENTER REAL-WORLD STUDY ON INOTUZUMAB AS A BRIDGE TO CELLULAR THERAPY IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Alicia Aguirre, 4160453

CLINICAL EFFICACY ANALYSIS OF CAR-T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH EXTRAMEDULLARY DISEASE

EHA Library, Zhao defeng, 4160454

DEFIBROTIDE TREATMENT OUTCOMES IN PATIENTS WITH VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) OCCURRING AFTER EXPOSURE TO INOTUZUMAB (INO) OR GEMTUZUMAB (GO)

EHA Library, Mohamad Mohty, 4160460

REAL-WORLD OUTCOMES OF PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS TREATED WITH A PEDIATRIC-INSPIRED PROTOCOL: A COMPARISON ACROSS TWO TIME PERIODS

EHA Library, Maria Agustina Perusini, 4160468

COMBINATION OF VENETOCLAX AND DARATUMUMAB PLUS CAG REGIMEN IS AN EFFECTIVE TRANSPLANT BRIDGING REGIMEN IN ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH POSITIVE MINIMAL RESIDUAL DISEASE

EHA Library, Li-Jun Peng, 4160469

TARGETING MUTANT TP53 ACUTE MYELOID LEUKEMIA THROUGH DISRUPTION OF MYC-GSPT1 AXIS

EHA Library, Michael Andreeff, 4160474

EPIGENETIC REGULATION OF ALDH1 BY ANTHRACYCLINES DRIVES CHEMORESISTANCE IN AML AND UNVEILS A THERAPEUTIC VULNERABILITY FOR CO-TARGETING WITH DNA METHYLATION INHIBITORS

EHA Library, Mileidys Perez, 4160475

CHARACTERIZATION OF A NOVEL MOLECULAR DEPENDENCY IN HOXA9/MEIS1+ ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Federica Valigi, 4160477

SINGLE-CELL PROFILING IDENTIFIES LEUKEMIC STEM CELL SUBTYPES LINKED TO ATRA SENSITIVITY IN RAS MUTANT ACUTE MYELOID LEUKEMIA

EHA Library, Diego A Pereira-Martins, 4160484

PEDIATRIC AML BLASTS PROMOTE AN IMMUNOSUPPRESSIVE M2-LIKE PHENOTYPE BY REPROGRAMMING MACROPHAGE METABOLISM.

EHA Library, Alicia Perzolli, 4160485

DISRUPTING MITOCHONDRIAL FUNCTION IN ACUTE MYELOID LEUKEMIA: PERSONALIZED APPROACH TO THERAPEUTIC STRATEGY COMBINING BCL-2 INHIBITION WITH COMPLEX I BLOCKADE

EHA Library, Natalia Baran, 4160490

MANNOSE METABOLISM INHIBITION IS TOXIC TOWARDS ACUTE MYELOID LEUKAEMIA STEM CELLS WHILE SPARING NORMAL HAEMATOPOIETIC CELLS AT STEADY STATE.

EHA Library, Samantha Mason, 4160493

JAK2 R1063H GERMLINE VARIANT IN AML: ASSOCIATION WITH ONCOGENIC IDH1/2 DRIVERS RESULTING IN COOPERATIVE LEUKEMOGENESIS AND THERAPEUTIC IMPLICATIONS

EHA Library, Katarina Hlusickova Kapralova, 4160494

HIGH THROUGHPUT DRUG SCREEN COUPLED TO PROTEO-GENOMIC DATA IDENTIFIES EPIGENETIC VULNERABILITIES IN AML SUBTYPE-SPECIFIC PATIENT GROUP

EHA Library, Shanna Hogeling, 4160495

DRUG PERSISTENCE TO RESISTANCE EVOLUTION ANALYSIS IN HUMAN LEUKEMIA REVEALS DIVERSE LEUKEMIA-INITIATING CELL PHENOTYPES

EHA Library, Michael Milyavsky, 4160496

DECODING ACUTE MYELOID LEUKAEMIA: INTEGRATING FUNCTIONAL PHENOTYPES WITH GENOMICS

EHA Library, Prasad Iyer, 4160497

P16INK4A SUPPRESSION BY FLT3-ITD ENHANCES AML PROGRESSION: MECHANISTIC INSIGHTS AND THERAPEUTIC TARGETING OF EPIGENETIC REGULATORS

EHA Library, jiarui zheng, 4160498

RGT-61159, A POTENT AND SELECTIVE SMALL MOLECULE MYB RNA INHIBITOR, SHOWED SIGNIFICANT ANTI-TUMOR ACTIVITY AS MONOTHERAPY OR IN COMBINATION WITH STANDARDS OF CARE IN SEVERAL LEUKEMIA DISEASE MODELS HARBORING AML MOST COMMON GENETIC LESIONS

EHA Library, Patricia Soulard, 4160500

TARGETING DNA REPLICATION AND THE INTRA-S-PHASE CHECKPOINT FOR TREATMENT OF TP53-MUTATED AML

EHA Library, Sean Post, 4160502

ACTIVIN A INHIBITION IMPAIRED IN VITRO AML CELL MIGRATION AND IN VIVO BONE MARROW ENGRAFTMENT IN MICE

EHA Library, Blake Moses, 4160503

COMPLEMENTARITY OF HIGH-THROUGHPUT SEQUENCING AND FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE IN AML: A REAL LIFE STUDY FROM THE HAUTS-DE-FRANCE OBSERVATORY

EHA Library, Augustin Boudry, 4160505

THE TRANSCRIPTIONAL LANDSCAPE OF CLONAL AND MICROENVIRONMENT CELLS IN ACUTE MYELOID LEUKEMIA TREATED WITH HMA-VENETOCLAX AT SINGLE CELL LEVEL

EHA Library, Alfredo Marchetti, 4160506

TARGETING METABOLIC ALTERATIONS IN PML::RARα+ MYELOID CELLS TO OVERCOME RESISTANCE AND RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA.

EHA Library, Nelida I. Noguera, 4160507

HPK1 INHIBITOR BGB-15025 INDUCES APOPTOSIS IN AML CELLS THROUGH CELL CYCLE PATHWAY AND MAPK/ERK SIGNALING AXIS.

EHA Library, Shiyu Yang, 4160510

INTEGRATIVE SYSTEMS BIOLOGY APPROACH UTILIZING TRANSCRIPTOMIC AND MUTATIONAL PROFILES TO UNVEIL PROGNOSIS-ASSOCIATED MOLECULAR PATHWAYS IN ACUTE MYELOID LEUKEMIA

EHA Library, Xiaoxue Wang, 4160512

DEEP TARGETED SEQUENCING TO MONITOR MEASURABLE RESIDUAL DISEASE AND CHIMERISM IN MIELOID MALIGANCIES AFTER ALLOGENIC STEM CELL TRANSPLANT

EHA Library, Irene Zamanillo, 4160514

SELECTIVE THERAPEUTIC TARGETING ON MNX1-DRIVEN PROGRAMS IN INFANT AML

EHA Library, Ylenia Cicirò, 4160515

TRANSCRIPTOMIC AND CELLULAR DECONVOLUTION ANALYSIS REVEALS DISTINCT PROFILES ASSOCIATED WITH CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Alba Mora, 4160521

RIPK3 INDUCES APOPTOSIS IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA CELLS VIA REGULATION OF MFN2-MEDIATED MITOCHONDRIAL FUSION

EHA Library, yan zhang, 4160523

STUDY ON THE SYNTHETIC LETHAL MECHANISM OF SELECTIVE KILLING OF ALDH2 DEFICIENT ACUTE MYELOID LEUKEMIA CELLS BY INHIBITING BRIP1

EHA Library, Jishi Wang, 4160524

ADVANCING NK CELL IMMUNOTHERAPY IN AML AND OVERCOMING CYTOKINE-DRIVEN ADAPTIVE RESISTANCE

EHA Library, Monika Sponheimer, 4160525

FROM XENOGRAFT TO PATIENT: THE IMPACT OF SURFACE MARKERS ON AML EXTRAMEDULLARY INVASION

EHA Library, Matteo Caridi, 4160527

PROGNOSTIC IMPACT OF FLT3-ITD LENGTH AND CLONAL PERSISTENCE IN MYELOID NEOPLASMS

EHA Library, Suresh Balasubramanian, 4160530

SPHINGOSINE-1-PHOSPHATE (S1P) MODULATOR FTY720 SYNERGIZES WITH VENETOCLAX IN AML THROUGH MTOR PATHWAY SUPPRESSION, MITOCHONDRIAL DAMAGE, AND LYSOSOMAL STRESS INDUCTION

EHA Library, Katia Beider, 4160533

A NEW ALGORITHM FOR HARMONIZING LARGE-SCALE RNA-SEQ INTEGRATION IN AML: ENABLING PLATFORM FOR DEEP ANALYSIS AND DISCOVERY

EHA Library, Matteo Caridi, 4160539

PATIENTS WITH RELAPSED OR REFRACTORY (R/R) NUCLEOPHOSMIN 1-MUTATED (NPM1M) ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 2 AUGMENT-101 STUDY

EHA Library, Martha L Arellano, 4160543

A PHASE IB/2 TRIAL OF AN ALL-ORAL „TRIPLET” REGIMEN FOR IDH-MUTATED MYELOID MALIGNANCIES: DECITABINE/CEDAZURIDINE AND VENETOCLAX IN COMBINATION WITH IVOSIDENIB/ENASIDENIB

EHA Library, Jennifer Marvin-Peek, 4160547

UPDATED RESULTS AND LONGER FOLLOW-UP FROM THE AUGMENT-101 PHASE 2 STUDY OF REVUMENIB IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) KMT2AR ACUTE LEUKEMIA

EHA Library, Ibrahim Aldoss, 4160549

CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES IN 405 ADULT PATIENTS WITH MIXED PHENOTYPE ACUTE LEUKEMIA: A STUDY FROM THE PETHEMA AND PALG GROUPS

EHA Library, Marta Sobas, 4160550

IS MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENT BY MULTIPARAMETER FLOW CYTOMETRY (MFC) A VALID EARLY ENDPOINT OF TREATMENT EFFICACY IN ACUTE MYELOID LEUKEMIA (AML): A PETHEMA STUDY IN 2,819 PATIENTS

EHA Library, Bruno Paiva, 4160551

UNVEILING DISTINCT MOLECULAR AND PROGNOSTIC FEATURES: AN RNA-BASED PROGNOSTIC MODEL FOR INFANT ACUTE MYELOID LEUKEMIA

EHA Library, YU TAO, 4160553

PHASE II STUDY OF CLADRIBINE WITH LOW DOSE CYTARABINE AND VENETOCLAX ALTERNATING WITH AZACYTIDINE AND VENETOCLAX FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Alex Bataller, 4160556

SECOND INDUCTION CYCLE BEFORE ALLOHSCT DOES NOT IMPROVE SURVIVAL IN ADVERSE-RISK AML PATIENTS IN COMPLETE REMISSION AFTER FIRST INDUCTION

EHA Library, Lukas Haaksma, 4160557

HIGH EFFICIENCY OF SALVAGE THERAPY COMBINING 7 DAYS VENETOCLAX AND G-CSF, FLUDARABINE, HIGH-DOSE CYTARABINE, AND MITOXANTRONE FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY ACUTE MYELOBLASTIC LEUKEMIA

EHA Library, Ahmad Ibrahim, 4160558

IMPACT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION ON PROGNOSIS IN ACUTE MYELOID LEUKEMIA WITH DIFFERENT CEBPA MUTATION SUBTYPES

EHA Library, Xiaohui Zhang, 4160565

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN): PROGNOSTIC FACTORS AND TREATMENT OUTCOMES IN 69 MAYO CLINIC PATIENTS

EHA Library, Erica Andres, 4160569

CONSTRUCTION OF A PROGNOSTIC MODEL FOR ACUTE MYELOID LEUKEMIA BASED ON FLOW CYTOMETRY IMMUNOPHENOTYPING USING MACHINE LEARNING METHODS.

EHA Library, Qing Ma, 4160571

PROGNOSTIC VALUE OF IDH1 AND IDH2 MUTATIONS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA

EHA Library, Guillermo Ramil, 4160573

A NOVEL RANDOM SURVIVAL FOREST MODEL FOR ADULT NPM1-MUTATED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Yiyi Yao, 4160576

REVUMENIB ACTIVITY IN PATIENTS WITH ACUTE LEUKEMIA WITH NUP98R: RESULTS FROM THE AUGMENT-101 PHASE 1 STUDY

EHA Library, Ghayas Issa, 4160577

COMPARABLE SURVIVAL OUTCOMES FOR SECONDARY AND DE NOVO ACUTE MYELOID LEUKEMIA AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Kehan Zhang, 4160579

IMPACT OF TYROSINE KINASE INHIBITORS ON OUTCOMES IN PHILADELPHIA CHROMOSOME-POSITIVE MIXED PHENOTYPE ACUTE LEUKEMIA: DATA FROM THE PETHEMA/PALG REGISTRY

EHA Library, Marta Sobas, 4160580

GENETIC ABNORMALITIES PREDICT OUTCOMES IN ACUTE MYELOID LEUKEMIA PATIENTS WITH CEBPA IN-FRAME MUTATIONS

EHA Library, Shunjie Yu, 4160581

NGS VS DIGITAL PCR FOR MRD MONITORING IN ACUTE MYELOID LEUKEMIA: A COMPARATIVE STUDY

EHA Library, Guillermo Ramil, 4160582

REAL-WORLD PATTERNS AND OUTCOMES IN AML PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: DATA FROM THE PETHEMA REGISTRY

EHA Library, Laura Torres Miñana, 4160584

REAL WORLD OUTCOMES OF ADULT PATIENTS WITH NUP98 GENE REARRANGED ACUTE MYELOID LEUKEMIA

EHA Library, Laura Torres Miñana, 4160590

PROGNOSTIC IMPACT OF EXTRAMEDULLARY DISEASE IN ACUTE MYELOID LEUKEMIA: A META-ANALYSIS

EHA Library, Yufan Lin, 4160594

COVALENT FLT3 INHIBITOR BMF-500 IN RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIA (AL): PRELIMINARY PHASE 1 DATA FROM THE COVALENT-103 STUDY (NCT05918692)

EHA Library, Farhad Ravandi-Kashani, 4160595

TREATMENT INTENSITY IS ASSOCIATED WITH DISTINCT LONGITUDINAL TRAJECTORIES OF FRAILTY IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Victoria Ling, 4160598

VENETOCLAX PLUS MITOXANTRONE HYDROCHLORIDE LIPOSOME AND AZACITIDINE AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Weiwei Qin, 4160600

TWICE WEEKLY LOW DOSE DECITABINE PLUS VENETOCLAX VERSUS AZACYTIDINE PLUS VENETOCLAX IN THE FRONTLINE TREATMENT OF ACUTE MYELOID LEUKEMIA, INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Ciprian Tomuleasa, 4160601

MEASURABLE MINIMAL RESIDUAL DISEASE BY AN ULTRA-SENSITIVE NGS METHOD TO EVALUATE THE RESPONSE IN ACUTE MYELOID LEUKEMIA, THE VENAQUI CLINICAL TRIAL

EHA Library, Rosa María Ayala Díaz, 4160608

VEN-BASED SCHEMES, ARE THEY BETTER THAN '3 + 7'?

EHA Library, Pedro Amorim Machado, 4160610

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH AML FROM 65 TO 74 YEARS UNFIT FOR FIRST-LINE INTENSIVE CHEMOTHERAPY IN JAPAN.

EHA Library, Fumiaki Fujii, 4160612

HEALTHCARE RESOURCE UTILIZATION IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX COMPARED TO HIGH- AND LOW-INTENSITY NON-VENETOCLAX THERAPIES

EHA Library, Pinkal Desai, 4160614

PROGNOSTIC IMPACT OF THE AML60+ SCORE FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH HYPOMETHYLATING AGENTS

EHA Library, Tobias Silzle, 4160615

SURVIVAL ANALYSIS OF LONG-TERM TREATMENT WITH VENETOCLAX-AZACITIDINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: MULTICENTRE REAL-WORLD OUTCOMES IN CHINA

EHA Library, Jing Zou, 4160617

EFFECT OF OBESITY ON OVERALL SURVIVAL IN ELDERLY PATIENTS (>65 YEARS OLD) WITH ACUTE MYELOID LEUKEMIA - SINGLE-CENTER EXPERIENCE.

EHA Library, Karolina Bełdzińska-Gądek, 4160622

UNVEILING STAT3-DRIVEN CIRCULAR RNAS ALTERATIONS IN T-LARGE GRANULAR LYMPHOCYTE LEUKEMIA (T-LGLL)

EHA Library, Elisa Rampazzo, 4160633

CONTROLLED PERFUSION OF A VASCULARIZED SCAFFOLD WITHIN A 3D PRINTED BIOREACTOR TO STUDY CLL CELLS TRAFFICKING

EHA Library, Riccardo Pinos, 4160634

UNCOVERING A CRITICAL ROLE FOR VAV1 IN α4ß1-BCR CROSSTALK IN CHRONIC LYMPHOCYTIC LEUKAEMIA: NOVEL INSIGHTS INTO DISEASE MECHANISMS

EHA Library, Tahera Alnassfan, 4160637

ALLOGENEIC STEM CELL TRANSPLANTATION IS EFFECTIVE AFTER PATHWAY INHIBITOR TREATMENTS IN CLL; A RETROSPECTIVE STUDY ON BEHALF OF THE CHRONIC MALIGNANCIES WORKING PARTY OF THE EBMT

EHA Library, Michel van Gelder, 4160639

MRD GUIDED MESUTOCLAX PLUS ORELABRUTINIB FOR CLL/SLL DEMONSTRATES HIGH RESPONSE AND EARLY MRD CLEARANCE WITH GOOD TOLERABILITY: PRELIMINARY ANALYSIS FROM AN ONGOING PHASE II DOSE OPTIMIZATION STUDY

EHA Library, Yang Liang, 4160642

10-YEAR FOLLOW-UP OF A RANDOMIZED PHASE-2 STUDY OF IBRUTINIB OR IBRUTINIB PLUS RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Jan Burger, 4160645

TREATMENT EFFECTIVENESS IN PATIENTS (PTS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING VENETOCLAX-BASED THERAPY AFTER PROGRESSION ON A COVALENT BRUTON TYROSINE KINASE INHIBITOR (CBTKI)

EHA Library, Beenish Manzoor, 4160648

IMPACT OF IBRUTINIB ON QUALITY OF LIFE IN PATIENTS WITH EARLY-STAGE, ASYMPTOMATIC CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS FROM THE PHASE III CLL12 TRIAL - MATCHING SAFETY TO PATIENT-REPORTED OUTCOMES

EHA Library, Ellinor Goergen, 4160651

DEVELOPMENT OF A CLINICAL MACHINE LEARNING TOOL FOR THE PREDICTION OF AUTOIMMUNE HEMOLYTIC ANEMIA IN CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION BASED MULTILAYER PERCEPTRON MODEL

EHA Library, Rayan Ramadan, 4160652